TI
VIVO

Telemetry Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Telemetry Investments’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$674K Buy
20,285
+1,585
+8% +$51.1K 1.06% 25
2022
Q3 		$590K Buy
+18,700
New +$606K 0.76% 39

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Telemetry Investments's VIVO Position: Q4 2022 in Review

Telemetry Investments increased its Meridian Bioscience Inc (VIVO) stake by 8.5% in Q4 2022, buying an estimated $51.1K and bringing the position to 20,285 shares worth $674K. The position accounts for 1.06% of the portfolio, ranked #25.

Telemetry Investments first reported a position in VIVO in Q3 2022 and has held it in 2 quarters since. 217 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

  • Telemetry Investments held 20,285 shares of Meridian Bioscience Inc worth $674K as of Q4 2022.
  • Telemetry Investments bought 1,585 Meridian Bioscience Inc shares in Q4 2022, an estimated $51.1K.
  • Meridian Bioscience Inc made up 1.06% of Telemetry Investments's portfolio in Q4 2022, its #25 holding.
  • Telemetry Investments first reported a position in Meridian Bioscience Inc in Q3 2022 and has held it in 2 quarters since.
  • 217 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.